Ipamorelin user experiences: what users themselves report

Users’ own accounts, not research. The accounts are self-selected and prove neither that it works nor that it is safe.

This page does not list users’ doses or sellers, and no figure on it is a recommendation. Doses used in studies, with sources: Ipamorelin dosage in studies.

In short

Of 76 people, 31 (41%) said ipamorelin brought some benefit and 53 (70%) some harm.

Where the accounts come from and how we read them

Sources: the Reddit forums r/Peptides (53 accounts), r/Biohackers (18), r/Tesamorelin (3), r/bpc_157 (2) and r/Retatrutide (1), 14 Oct 2024 to 4 Oct 2026. The posts were retrieved from a public Reddit archive. From first-person posts about ipamorelin, 300 were picked at random, and every one was read.

Coding: for each account we recorded the route, reported benefits and harms, how strong a harm was, whether and why the person stopped, length of use and other substances used at the same time. We kept accounts that reported some effect, some harm, or no effect. Questions and plans were left out. A harm was recorded when the person reported it during use, even if the cause was uncertain. Several posts by one person count as one person. One person can mention several things, so the shares in the tables do not add up to 100.

Check: an AI model read and classified the posts following written instructions. A second, separate AI run classified a random tenth (30 posts) again without seeing the first classification. The main fields matched: 30/30 (100%).

Whose accounts these are: routes mentioned: injection 75; the others did not say. The figures describe the writers and are not a recommendation. The products were not verified, so we do not know what people actually took.

Did ipamorelin help? The overall picture

Of 76 people, 16 (21%) reported benefit only, 15 (20%) both benefit and harm, 38 (50%) harm only and 7 (9%) neither.

Stopping. 14 people (18%) said they stopped or paused: 13 because of harms and 1 because they noticed no effect or for another reason.

Share = people / 76.
Overall picture: benefit, harm or neitherPeopleShare
Benefit only1621%
Both benefit and harm1520%
Harm only3850%
Neither benefit nor harm79%

Most common reported benefits

Of 76 people. 31 (41%) mentioned some benefit; the table lists every benefit reported.

ReportedPeopleShare
Better sleep1216%
Muscle or strength912%
Fat loss or smaller waist811%
IGF-1 rose on a lab test68%
Faster recovery57%
Mood or wellbeing23%
More appetite or weight gain (wanted)11%
Energy or alertness11%
Less joint or other pain11%
Skin, hair or nails11%
Other benefit57%

Share = people / 76.

Most common reported harms

Of 76 people. 53 (70%) mentioned some harm; 1 said explicitly they had none.

ReportedPeopleShare
Allergic reaction, hives or rash1317%
Injection site reaction1216%
Flushing or head rush after the shot912%
Sleep problems912%
Fatigue or lethargy68%
Numbness, tingling or carpal tunnel symptoms57%
Anxiety, irritability or low mood45%
Heart or blood pressure45%
Strong hunger (unwanted)34%
Higher blood sugar or insulin resistance34%
Water retention or swelling34%
Headache23%
Nausea or stomach upset11%
Joint or muscle pain11%
Other, rarer harm912%

Share = people / 76.

How severe were the harms?

Of the 53 people who described how strong a harm was, 25 (47%) described it as mild, 24 (45%) as clearly bothersome and 4 (8%) as severe. The strength is the writer's own description, not a doctor's assessment.

Share = people / 53.
Strength of the harm as the writer described itPeopleShare
Mild: minor and manageable2547%
Clearly bothersome: several days, sleep or work affected2445%
Severe: emergency visit, hospital or unable to function48%

Harms known from research and regulators: What side effects does ipamorelin have?

How long did people use ipamorelin?

49 of 76 people (64%) said how long they had been using it at the time of writing. Where one person wrote several posts, the longest stated time counts.

Share = people / 49.
Stated length of usePeopleShare
Under a week918%
1-4 weeks1224%
1-3 months2449%
Over 3 months48%

Many people post partway through, often in the first days or as soon as harms start, so short times are over-represented. The numbers describe the writers; they do not say how long it should be used.

Other substances at the same time

70 of 76 people (92%) used other substances at the same time. The most common: CJC-1295 (46), tesamorelin (22) and BPC-157 (15). Then the account cannot tell which substance had the effect.

About dosing

We do not repeat the amounts or ways of use people mention, and we give no dosing or how-to instructions. A safe dose is not known. Doses used in studies, with sources: Ipamorelin dosage in studies. Legal status: Is ipamorelin legal in Finland?

What can be concluded?

Harms were reported more often than benefits, most often allergic-type and injection-site reactions. Because almost everyone used ipamorelin with other substances, the accounts cannot separate what it did.

The accounts prove neither that it works nor that it is safe. The writers are self-selected, the product contents are unknown, many used several substances at once, and placebo effects can be large. The research and its evidence levels: Ipamorelin: what the research shows.

Quotes

Short excerpts in the writers’ own words. Writers’ names and links are not shown. We picked quotes from every group: benefit, both benefit and harm, no effect, harms and people who stopped.

Other summaries made with the same method: BPC-157 user experiences, CJC-1295 user experiences, MK-677 user experiences, Tesamorelin user experiences, Sermorelin user experiences, AOD-9604 user experiences, CJC-1295 + ipamorelin blend user experiences and user experiences with collagen and skin peptides.

Content is general information about research, not medical advice. If you have symptoms, contact a healthcare professional.